SCHEMBL7658698

SCHEMBL7658698

O=[N+]([O-])c1ccc(CS(=O)(=O)Cl)c([N+](=O)[O-])c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
ALDH1A1 P00352 5/20 0.49
MAPK1 P28482 2/20 0.49
HIF1A Q16665 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
TDP1 Q9NUW8 2/20 0.49
GPR35 Q9HC97 2/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TXNRD1 Q16881 1/20 0.46
TXNRD3 Q86VQ6 1/20 0.46
TXNRD2 Q9NNW7 1/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3590165 0.85 CYP1A2 (0.54) CYP1A2ALDH1A1MAPK1HIF1ACYP3A4
SCHEMBL31735937 0.83 MAPK1 (0.49) ALDH1A1MAPK1TSHRSMN1; SMN2MEN1
SCHEMBL384310 0.83 CYP1A2 (0.59) CYP1A2ALDH1A1MAPK1HIF1ACYP3A4
SCHEMBL3551072 0.83 MAPK1 (0.49) ALDH1A1MAPK1TSHRSMN1; SMN2MEN1
SCHEMBL7072191 0.80 ALDH1A1 (0.55) ALDH1A1CYP3A4TDP1TSHRMAPT
SCHEMBL31692133 0.80 ALDH1A1 (0.51) CYP1A2ALDH1A1MAPK1HIF1ACYP3A4
SCHEMBL3256690 0.80 ALDH1A1 (0.51) CYP1A2ALDH1A1MAPK1HIF1ACYP3A4
SCHEMBL27961047 0.80 CYP1A2 (0.68) CYP1A2ALDH1A1MAPK1HIF1ACYP3A4
SCHEMBL3136616 0.79 CYP1A2 (0.62) CYP1A2ALDH1A1MAPK1HIF1ACYP3A4
SCHEMBL5333075 0.78 CYP1A2 (0.66) CYP1A2ALDH1A1MAPK1HIF1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085861-A1 IMIDAZOLIDINE COMPOUNDS AND THEIR USE AS CXCR3 ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-31 WO disclosed
US-6469002-B1 COMPOUNDS WHICH MODULATE CHEMOKINE RECEPTOR ACTIVITY AND ARE USEFUL IN TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. 2002-10-22 US disclosed
EP-0627443-B1 3,4'-DIDEOXYMYCAMINOSYLTYLONOLIDE DERIVATIVE AND PRODUCTION THEREOF ZAIDAN HOJIN BISEIBUTSU (JP) 1997-03-26 EP disclosed
US-5541303-A 3,4'-dideoxymycaminosltylonolide derivative and process for producing the same ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYUKAI (JP) 1996-07-30 US disclosed
EP-0627443-A1 3,4'-DIDEOXYMYCAMINOSYLTYLONOLIDE DERIVATIVE AND PRODUCTION THEREOF ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1994-12-07 EP disclosed